Comparative haemodynamic effects of clonidine and guanfacine. 1978

H F Oates, and L M Stoker, and E P MacCarthy, and J C Monaghan, and G S Stokes

Dose-response relationships were established for the acute effects on arterial pressure and heart rate of the antihypertensive agents, clonidine and guanfacine, administered intravenously or intramuscularly to anaesthetized rats. The intramuscular route appeared to be preferable to the intravenous, for the direct pressor potency of each drug was thereby greatly reduced in relation to the hypotensive efficacy. The potency of clonidine was 10-20 times that of guanfacine, but the same maximal fall in blood pressure was obtained with either agent administered by either route. Both agents caused a marked, dose-related suppression of plasma renin activity. When either clonidine or guanfacine was administered twice daily for 3 weeks and then discontinued, a phase of blood pressure overshoot with tachycardia commenced within 24 hr of the last injection. These withdrawal effects were more evident in guanfacine-treated rats than in clonidine-treated rats.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D010648 Phenylacetates Derivatives of phenylacetic acid. Included under this heading are a variety of acid forms, salts, esters, and amides that contain the benzeneacetic acid structure. Note that this class of compounds should not be confused with derivatives of phenyl acetate, which contain the PHENOL ester of ACETIC ACID. Benzeneacetates,Benzeneacetic Acids,Phenylacetic Acids,Acids, Benzeneacetic,Acids, Phenylacetic
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

H F Oates, and L M Stoker, and E P MacCarthy, and J C Monaghan, and G S Stokes
January 1980, British journal of clinical pharmacology,
H F Oates, and L M Stoker, and E P MacCarthy, and J C Monaghan, and G S Stokes
November 1984, Clinical pharmacology and therapeutics,
H F Oates, and L M Stoker, and E P MacCarthy, and J C Monaghan, and G S Stokes
October 1985, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
H F Oates, and L M Stoker, and E P MacCarthy, and J C Monaghan, and G S Stokes
March 1985, Clinical pharmacology and therapeutics,
H F Oates, and L M Stoker, and E P MacCarthy, and J C Monaghan, and G S Stokes
January 1984, Hypertension (Dallas, Tex. : 1979),
H F Oates, and L M Stoker, and E P MacCarthy, and J C Monaghan, and G S Stokes
May 1977, Journal of the Indian Medical Association,
H F Oates, and L M Stoker, and E P MacCarthy, and J C Monaghan, and G S Stokes
April 1985, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
H F Oates, and L M Stoker, and E P MacCarthy, and J C Monaghan, and G S Stokes
January 1980, British journal of clinical pharmacology,
H F Oates, and L M Stoker, and E P MacCarthy, and J C Monaghan, and G S Stokes
January 1980, British journal of clinical pharmacology,
H F Oates, and L M Stoker, and E P MacCarthy, and J C Monaghan, and G S Stokes
September 1982, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!